SpaceX confirma precio de colocación y se convertiría en la mayor apertura bursátil de la historia Ivar AI

BusinessLine

SpaceX IPO pushes Elon Musk’s net worth past $1 trillion

KQED

SpaceX Blasts Off With a Record-Breaking $75 Billion IPO

The Times of India

US stocks: SpaceX to make historic listing on Nasdaq on Friday that could make Elon Musk a trillionaire

36kr.com

SpaceX获得三大债券评级机构的投资级评级

CBS News

OpenAI says it filed confidential IPO as it positions itself for AI arms race

Crypto Briefing

Cynthia Lummis calls for US to accumulate Bitcoin openly while other nations buy quietly

Foreign Policy

Trump Says More Strikes on Iran Are Coming

Donanimhaber.com

Yapay zekâ savaşında altyapı yarışı kızışıyor: Çin, 295 milyar dolarlık dev yatırım hazırlıyor

BBC News

Live: US striking Iran in response to downing of helicopter, military says

Hipertextual

SpaceX sale a la bolsa por 1,77 billones de dólares: la mayor oferta pública de la historia

Olhardigital.com.br

SpaceX define ação a US$ 135 e bate recorde histórico de IPO

El Financiero

Histórico ‘despegue’ para SpaceX: Recauda 75 mil mdd tras debutar en bolsa y dispara la fortuna de Musk

Crypto Briefing

House passes sanctions on Russia and aid for Ukraine amid Senate uncertainty

Crypto Briefing

US launches strikes on Iran after Apache helicopter downed near Strait of Hormuz

Diariobitcoin.com

Stargate Finance (STG) se dispara un 96% el 11 de junio de 2026: ¿hay espacio para más ganancias?

New York Post

ChatGPT maker OpenAI files for IPO looking to capitalize on investor appetite for AI boom

Yahoo Entertainment

川普預告伊朗協議將至美股道瓊狂漲逾 900 點

The Times of India

US stocks: Oppenheimer launches Wall Street's first coverage of SpaceX with bullish outlook

Crypto Briefing

S&P 500 rallies nearly 2% as reports signal potential end to Iran conflict

CNBC

From startup to $1.8 trillion: The investors who took a chance on SpaceX now reap the rewards

Crypto Briefing

The Magnificent 7 report 4.3x revenue growth to $690B by Q1 2026

$Cellectis reçoit le statut RMAT de la FDA pour lasmé-cel, la première thérapie CAR-T allogénique en essai pivot pour les patients atteints de LLA-B en rechute ou réfractaire$

GlobeNewswire

Cellectis reçoit le statut RMAT de la FDA pour lasmé-cel, la première thérapie CAR-T allogénique en essai pivot pour les patients atteints de LLA-B en rechute ou réfractaire